Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy
Journal:
Current Drug Targets
Volume:
17
Page:
853-864
Author(s):
Zhiyu Wang, Pengxi Liu, Qianjun Chen, Shigui Deng, Xiaoyan Liu, Honglin Situ, Shaowen Zhong, Swei Hann and Yi Lin
Intra-uterine Growth Retardation as a Risk Factor of Postnatal Metabolic Disorders
Journal:
Current Pharmaceutical Biotechnology
Volume:
17
Page:
587-596
Author(s):
Radzislaw Mierzynski, Dominik Dluski, Dorota Darmochwal-Kolarz, Elzbieta Poniedziałek-Czajkowska, Bozena Leszczynska-Gorzelak, Zaneta Kimber-Trojnar, Agnieszka-Wankowicz and Jan Oleszczuk
What is the Current Role of Immunotherapy for Colon Cancer?
Journal:
Reviews on Recent Clinical Trials
Volume:
11
Page:
93-98
Author(s):
Fernando Galanternik, Gonzalo Recondo, Matías E. Valsecchi, Martín Greco, Gonzalo Recondo, Máximo de la Vega and E. Diaz Cantón
Molecular Mechanisms Underlying Psychological Stress and Cancer
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
2389-2402
Author(s):
Kyeong Jin Shin, Yu Jin Lee, Yong Ryoul Yang, Seorim Park, Pann-Ghill Suh, Matilde Yung Follo, Lucio Cocco and Sung Ho Ryu
Targeting Kinases in Cancer Therapies: Adverse Effects on Blood Platelets
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
2315-2322
Author(s):
Marie Levade, Sonia Severin, Marie-Pierre Gratacap, Loïc Ysebaert and Bernard Payrastre
Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
11
Page:
141-151
Author(s):
Xiao-Na Fang and Li-Wu Fu
A Review of the Recent Developments in Synthetic Anti-Breast Cancer Agents
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
16
Page:
668-685
Author(s):
Parvesh Singh, Nomandla Ngcoya and Vipan Kumar
Cucurbitacin B Enhances the Anticancer Effect of Imatinib Mesylate Through Inhibition of MMP-2 Expression in MCF-7 and SW480 Tumor Cell Lines
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
16
Page:
747-754
Author(s):
Filiz Bakar
Molecular Pharmacology of Malignant Pleural Mesothelioma: Challenges and Perspectives From Preclinical and Clinical Studies
Journal:
Current Drug Targets
Volume:
17
Page:
824-849
Author(s):
Stefano Thellung, Roberto E. Favoni, Roberto Würth, Mario Nizzari, Alessandra Pattarozzi, Antonio Daga, Tullio Florio and Federica Barbieri
The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development
Journal:
Current Molecular Medicine
Volume:
16
Page:
353-393
Author(s):
T.F. Sumter, L. Xian, T. Huso, M. Koo, Y.-T. Chang, T.N. Almasri, L. Chia, C. Inglis, D. Reid and L.M.S. Resar